Recently, we have reported treatment with an AT1 receptor blocker as well as the antioxidant reduced the oxidative stress, suggesting that these events are essential for the development of diabetic cardiomyopathy, and their inhibition improves molecular and pathological events in the diabetic myocardium [130]. Here, AGTR1 is linked to diabetic cardiomyopathy.